APASL consensus statements and recommendation on treatment of hepatitis C

Omata, Masao; Kanda, Tatsuo; Wei, Lai; Yu, Ming-Lung; Chuang, Wang-Long; Ibrahim, Alaaeldin; Lesmana, Cosmas; Sollano, Jose; Kumar, Manoj; Jindal, Ankur; Sharma, Barjesh; Hamid, Saeed; Dokmeci, A.; Mamun-Al-Mahtab, Mamun-Al-Mahtab; McCaughan, Geofferey; Wasim, Jafri; Crawford, Darrell; Kao, Jia-Horng; Yokosuka, Osamu; Lau, George; Sarin, Shiv

doi:10.1007/s12072-016-9717-6

APASL consensus statements and recommendation on treatment of hepatitis C

Copy For Citation

Omata M., Kanda T., Wei L., Yu M., Chuang W., Ibrahim A., ...More

HEPATOLOGY INTERNATIONAL, vol.10, no.5, pp.702-726, 2016 (SCI-Expanded)

Publication Type: Article / Article
Volume: 10 Issue: 5
Publication Date: 2016
Doi Number: 10.1007/s12072-016-9717-6
Journal Name: HEPATOLOGY INTERNATIONAL
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.702-726
Keywords: APASL, DAAs, HCV, Interferon-free, Turkey, VIRUS GENOTYPE 1, PEGYLATED INTERFERON-ALPHA, SOFOSBUVIR PLUS RIBAVIRIN, TREATMENT-NAIVE PATIENTS, SUSTAINED VIROLOGICAL RESPONSE, INTERLEUKIN-28B GENETIC-VARIANTS, TREATMENT-EXPERIENCED PATIENTS, PREVIOUSLY UNTREATED PATIENTS, FIXED-DOSE COMBINATION, OPEN-LABEL
Ankara University Affiliated: Yes

Abstract

The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the "APASL consensus statements and recommendation on management of hepatitis C" in March, 2015, in order to revise "APASL consensus statements and management algorithms for hepatitis C virus infection (Hepatol Int 6:409-435, 2012)". The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations on treatment of hepatitis C are presented in this review.